Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jan 1;30(1):10-19.
doi: 10.1097/LVT.0000000000000198. Epub 2023 Jun 29.

A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation

Affiliations
Randomized Controlled Trial

A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation

Marina Serper et al. Liver Transpl. .

Abstract

Frailty and impaired functional status are associated with adverse outcomes on the liver transplant (LT) waitlist and after transplantation. Prehabilitation prior to LT has rarely been tested. We conducted a 2-arm patient-randomized pilot trial to evaluate the feasibility and efficacy of a 14-week behavioral intervention to promote physical activity prior to LT. Thirty patients were randomized 2:1 to intervention (n = 20) versus control (n = 10). The intervention arm received financial incentives and text-based reminders linked to wearable fitness trackers. Daily step goals were increased by 15% in 2-week intervals. Weekly check-ins with study staff assessed barriers to physical activity. The primary outcomes were feasibility and acceptability. Secondary outcomes included mean end-of-study step counts, short physical performance battery, grip strength, and body composition by phase angle. We fit regression models for secondary outcomes with the arm as the exposure adjusting for baseline performance. The mean age was 61, 47% were female, and the median Model for End-stage Liver Disease sodium (MELD-Na) was 13. One-third were frail or prefrail by the liver frailty index, 40% had impaired mobility by short physical performance battery, nearly 40% had sarcopenia by bioimpedance phase angle, 23% had prior falls, and 53% had diabetes. Study retention was 27/30 (90%; 2 unenrolled from intervention, 1 lost to follow-up in control arm). Self-reported adherence to exercise during weekly check-ins was about 50%; the most common barriers were fatigue, weather, and liver-related symptoms. End-of-study step counts were nearly 1000 steps higher for intervention versus control: adjusted difference 997, 95% CI, 147-1847; p = 0.02. On average, the intervention group achieved daily step targets 51% of the time. A home-based intervention with financial incentives and text-based nudges was feasible, highly accepted, and increased daily steps in LT candidates with functional impairment and malnutrition.

PubMed Disclaimer

Conflict of interest statement

Peter Reese received grants from Merck and Gilead (Investigator initiated grants to my institution for trials of transplanting organs from donors infected with hepatitis C virus).

Marina Serper received grants from Grifols, SA.

K.Rajender Reddy consults for Novartis-DSMB. He advises for Spark Therapeutics, Novo Nordisk, Mallinckrodt-C. He has received grants from BMS, Mallinckrodt,Intercept, Exact Sciences, BioVie, Sequana, Grifols, HCC-TARGET, NASH-TARGET (Paid to the University of Pennsylvania) D.

Figures

Figure 1.
Figure 1.
Study Flow Diagram
Figure 2.
Figure 2.
Percent adherence to daily step count goals over each two-week interval among participants who completed the intervention
Figure 3.
Figure 3.
Steps counts by study arm by each two-week interval

References

    1. Lai JC, Covinsky KE, McCulloch CE, Feng S. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol 2018;113:235–242. - PMC - PubMed
    1. Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611–1644. - PMC - PubMed
    1. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, Esfandiari N, et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transplantation 2012;18:1209–1216. - PubMed
    1. Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35–51. - PubMed
    1. Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl 2017;23:625–633. - PMC - PubMed

Publication types